Oruka Therapeutics, Inc. Increase (Decrease) in Deferred Charges
Oruka Therapeutics, Inc. (ORKA) reported Increase (Decrease) in Deferred Charges of -$2.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2014-11-12
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2014-09-30 was -$1.00K, a 133.33% decline year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2013-12-31 was -$1.00K, a 112.50% decline year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2013-09-30 was $3.00K, a 66.67% decline year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2013-06-30 was $5.00K, a 79.17% decline year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for fiscal 2013 was $15.00K, a 54.55% decline from fiscal 2012.
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for fiscal 2012 was $33.00K, a 87.64% decline from fiscal 2011.
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for fiscal 2011 was $267.00K, a 134.21% increase from fiscal 2010.
- Oruka Therapeutics, Inc. increase (decrease) in deferred charges for fiscal 2010 was $114.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 3 month as first filed | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month | Increase (Decrease) in Deferred Charges 114 month | Increase (Decrease) in Deferred Charges 117 month | Increase (Decrease) in Deferred Charges 120 month | Increase (Decrease) in Deferred Charges 123 month | Increase (Decrease) in Deferred Charges 126 month | Increase (Decrease) in Deferred Charges 129 month | Increase (Decrease) in Deferred Charges 132 month | Increase (Decrease) in Deferred Charges 135 month | Increase (Decrease) in Deferred Charges 138 month | Increase (Decrease) in Deferred Charges 144 month | Increase (Decrease) in Deferred Charges 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$2.00K 10-Q · filed 2014-11-12 | ||||||||||||||
| 2014-06-30 | -$1.00K 10-Q · filed 2014-08-13 | |||||||||||||||
| 2014-03-31 | -$1.00K 10-Q · filed 2014-05-13 | |||||||||||||||
| 2013-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $2.00K derived: sum of 2 quarters · filed 2014-11-12 | $7.00K derived: sum of 3 quarters · filed 2014-11-12 | $15.00K 10-K · filed 2014-03-20 | -$1.00K 10-K · filed 2014-03-20 | |||||||||||
| 2013-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $8.00K derived: sum of 2 quarters · filed 2014-11-12 | $16.00K 10-Q · filed 2014-11-12 | $24.00K derived: sum of 4 quarters · filed 2014-11-12 | ||||||||||||
| 2013-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $13.00K 10-Q · filed 2014-08-13 | $21.00K derived: sum of 3 quarters · filed 2014-08-13 | $30.00K derived: sum of 4 quarters · filed 2014-08-13 | -$3.00K 10-Q · filed 2013-08-13 | |||||||||||
| 2013-03-31 | $8.00K 10-Q · filed 2014-05-13 | -$8.00K 10-Q · filed 2013-05-13 | $16.00K derived: sum of 2 quarters · filed 2014-05-13 | $25.00K derived: sum of 3 quarters · filed 2014-05-13 | $49.00K derived: sum of 4 quarters · filed 2014-05-13 | $8.00K 10-Q · filed 2013-05-13 | ||||||||||
| 2012-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $17.00K derived: sum of 2 quarters · filed 2014-03-20 | $41.00K derived: sum of 3 quarters · filed 2014-03-20 | $33.00K 10-K · filed 2014-03-20 | -$16.00K 10-K · filed 2013-03-21 | |||||||||||
| 2012-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $33.00K derived: sum of 2 quarters · filed 2013-11-13 | $25.00K 10-Q · filed 2013-11-13 | $33.00K derived: sum of 4 quarters · filed 2013-11-13 | -$24.00K 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $16.00K 10-Q · filed 2013-08-13 | $24.00K derived: sum of 3 quarters · filed 2013-08-13 | $32.00K derived: sum of 4 quarters · filed 2013-08-13 | -$33.00K 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | -$8.00K 10-Q · filed 2013-05-13 | $8.00K 10-Q · filed 2012-05-14 | $0.00 derived: sum of 2 quarters · filed 2013-05-13 | $8.00K derived: sum of 3 quarters · filed 2013-05-13 | $230.00K derived: sum of 4 quarters · filed 2013-05-13 | -$41.00K 10-Q · filed 2012-05-14 | ||||||||||
| 2011-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $16.00K derived: sum of 2 quarters · filed 2013-03-21 | $238.00K derived: sum of 3 quarters · filed 2013-03-21 | $267.00K 10-K · filed 2013-03-21 | -$49.00K 10-K · filed 2012-03-27 | |||||||||||
| 2011-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $230.00K derived: sum of 2 quarters · filed 2012-11-13 | $259.00K 10-Q · filed 2012-11-13 | $288.00K derived: sum of 4 quarters · filed 2012-11-13 | -$57.00K 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $251.00K 10-Q · filed 2012-08-13 | $280.00K derived: sum of 3 quarters · filed 2012-08-13 | $310.00K derived: sum of 4 quarters · filed 2012-08-13 | -$65.00K 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | $29.00K 10-Q · filed 2012-05-14 | $58.00K derived: sum of 2 quarters · filed 2012-05-14 | $88.00K derived: sum of 3 quarters · filed 2012-05-14 | |||||||||||||
| 2010-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $59.00K derived: sum of 2 quarters · filed 2012-03-27 | $114.00K 10-K · filed 2012-03-27 | |||||||||||||
| 2010-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $85.00K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $55.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |